“ANKRD22 enhances breast cancer cell malignancy by activating the Wnt/β-catenin pathway via modulating NuSAP1 expression” (2021) Biomolecules and Biomedicine, 21(3), pp. 294–304. doi:10.17305/bjbms.2020.4701.